HopeStage
Back to all studies
Not recruitingISRCTN65818527

Study Of Cognitive ReAlignment Therapy in Early Schizophrenia

Research studyAges 18–65United Kingdom
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
United Kingdom

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Not recruiting
Enrollment listed in the registry
Not clearly listed
Sponsor
Medical Research Council (MRC) (UK)
Sponsor type
Unknown or unclear
Study type
Other
Intervention type
Other / unclear
Locations
United Kingdom
Age range
From 18 Years to 65 Years
Official registry ID
ISRCTN65818527
Official title
Show the full official title

Study Of Cognitive ReAlignment Therapy in Early Schizophrenia

Recruitment & locations

Not recruiting

United Kingdom

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Medical Research Council (MRC) (UK).

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as not recruiting.

Want to explore more studies?

Explore studies